SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001479290-18-000038
Filing Date
2018-03-02
Accepted
2018-03-02 17:28:39
Documents
87
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rvnc1231201710k.htm 10-K 2626734
2 EXHIBIT 10.24 rvnc1231201710kex1024-amen.htm EX-10.24 141222
3 EXHIBIT 10.26 rvnc1231201710kex1026-2018.htm EX-10.26 5074
4 EXHIBIT 21.1 rvnc1231201710kex211-listo.htm EX-21.1 2969
5 EXHIBIT 23.1 rvnc1231201710kex231-conse.htm EX-23.1 2565
6 EXHIBIT 31.1 rvnc1231201710kex311-certi.htm EX-31.1 9159
7 EXHIBIT 31.2 rvnc1231201710kex312-certi.htm EX-31.2 9333
8 EXHIBIT 32.1 rvnc1231201710kex321-certi.htm EX-32.1 7101
9 EXHIBIT 32.2 rvnc1231201710kex322-certi.htm EX-32.2 7136
16 GRAPHIC rvnctotalreturnchart.jpg GRAPHIC 129650
  Complete submission text file 0001479290-18-000038.txt   10548660

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT rvnc-20171231.xml EX-101.INS 2168443
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rvnc-20171231.xsd EX-101.SCH 59284
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rvnc-20171231_cal.xml EX-101.CAL 86894
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rvnc-20171231_def.xml EX-101.DEF 329341
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rvnc-20171231_lab.xml EX-101.LAB 861097
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rvnc-20171231_pre.xml EX-101.PRE 505936
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36297 | Film No.: 18663486
SIC: 2834 Pharmaceutical Preparations